FundedIQ
Biotechnology

Cellino Biotech: Funding, Investors & Team (Sep 2026)

Cellino Biotech develops intracellular delivery lasers and nanotechnology for gene editing applications. The company makes stem cell differentiation a digital process, applying the latest tools from optics, biology, and computation to engineer functionally mature cells. Its technology enables the acceleration of the development time of engineered cells from years to weeks.

www.cellinobio.com LinkedIn Cambridge, United States 11-50 employees
Biotechnology Nanotechnology Product Design
Total raised
$121M
Rounds
3
Latest
Undisclosed round
Sep 2024

Cellino Biotech has raised $121M across 3 funding rounds on record, the most recent an undisclosed round of $25.0M announced in Sep 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Cellino Biotech Company Profile and Key Stats

Total funding raised
$121M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$25.0M in Sep 2024
Employees
11-50
reported band
Headquarters
Cambridge, United States

Latest funding round on record: Sep 2024.

Cellino Biotech Funding Rounds

Date
Round
Amount
Undisclosed round
$25.0M
Series A
$80.0M
Seed
$16.0M

Cellino Biotech raised $16.0M in a Seed announced in Feb 2021.

11 months later, a Series A of $80.0M was announced in Jan 2022.

2.7 years later, an undisclosed round of $25.0M was announced in Sep 2024.

Cellino Biotech Founders and Leadership Team

Name
Role
Contact
Matthias Wagner
Founder
Nabiha Saklayen
CEO
Locked

Contact details for the Cellino Biotech team: 1 of 2 have an email address on file.

Start 14-day free trial →

Cellino Biotech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Cellino Biotech's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Cellino Biotech in Biotechnology and Cambridge

Companies Similar to Cellino Biotech

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Cellino Biotech Funding FAQs

What does Cellino Biotech do?

Cellino Biotech develops intracellular delivery lasers and nanotechnology for gene editing applications. The company makes stem cell differentiation a digital process, applying the latest tools from optics, biology, and computation to engineer functionally mature cells. Its technology enables the acceleration of the development time of engineered cells from years to weeks.

How much funding has Cellino Biotech raised?

Cellino Biotech has raised $121M across 3 rounds on record. The most recent is an undisclosed round of $25.0M announced in Sep 2024.

When did Cellino Biotech last raise funding?

Cellino Biotech's most recent funding round on record is an undisclosed round of $25.0M, announced in Sep 2024.

Who founded Cellino Biotech?

FundedIQ lists Matthias Wagner (Founder) at Cellino Biotech.

Who is the CEO of Cellino Biotech?

Nabiha Saklayen is listed as CEO at Cellino Biotech.

Where is Cellino Biotech headquartered?

Cellino Biotech is based in Cambridge, Massachusetts, United States.

How many employees does Cellino Biotech have?

Cellino Biotech is in the 11-50 employee band.

How does Cellino Biotech's funding compare to other Biotechnology startups?

Cellino Biotech's latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Cellino Biotech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cellino Biotech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.